/PRNewswire/ Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval and.
Cochlear receives FDA clearance of Baha 6 Max, industry s smallest 55 dB sound processor now with direct Android streaming
- The Baha 6 Max Sound Processor has a fitting range of up to 55 dB SNHL in the same small size as the industry s current 45 dB devices.
- It is also the first bone conduction sound processor to offer direct streaming from Apple and Android devices, as well as many other new features.
- Processor is indicated for people with SSD (single-sided deafness), conductive or mixed hearing loss.
News provided by
Share this article
Share this article
LONE TREE, Colo., March 8, 2021 /PRNewswire/ Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announces the U.S. Food and Drug Administration (FDA) clearance of the new Cochlear™ Baha® 6 Max Sound Processor, designed to improve hearing outcomes for people with SSD (single-sided deafness), conductive or mixed hearing loss.